alexa Ahmed Lasfar | University of Medicine and Dentistry of
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ahmed Lasfar

Ahmed Lasfar Ahmed Lasfar
University Hospital Cancer Center
University of Medicine and Dentistry of New Jersey

Dr. Ahmed Lasfar is a Researcher working on improving the use of Interferon in cancer and determining the mechanisms of resistance to interferon therapy at the University Hospital Cancer Center New Jersey Medical School/University of Medicine and Dentistry of New Jersey. He is a member of the Department of Biochemistry and Molecular Biology at NJMS/UMDNJ. He has completed his Post Doctoral training 1999-2002 in the Department of Molecular Genetics Microbiology and Immunology at Robert Wood Johnson Medical School UMDNJ under the supervision of Dr. Sidney Pestka Leader for the approval of IFN use in Clinic by the FDA in 1986 and the winner of the National Medal of Technology in 2002. Dr. Ahmed lasfar has received a PhD in Immunology from Paris University of Science France in 1996. He has completed his Master Degree in Rene Descartes University School of Medicine France 1992. He received several awards including two excellence scientific awards from the New Jersey Commission on Cancer Research and one award from the International Society for Interferon and Cytokine Research.

Research Interest

- Interferon lambda signaling in normal and cancer cells
- Strategies for the improvement of interferon treatment in melanoma
- Role of Interferon lambdas in Hepatocelluar Carcinoma
- Mechanisms of TGF beta resistance
- Interaction between TGF beta and Interferons.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version